CommercialCoverageMedium impact
Wegovy Injectable Coverage Expands for MASH Diagnosis
Blue Cross Blue Shield of North Dakota·ND · Endocrinology, Gastroenterology, Family Medicine +1 more·Provider News
Effective date
Feb 5, 2026
We identified it
Jun 19, 2026
Summary
BCBSND now covers Wegovy injectable for commercial members diagnosed with MASH (formerly NASH), regardless of their plan's weight loss benefits. Members may need new prior authorization for the MASH diagnosis if their weight loss benefits changed in 2026.
Action Required
Immediately: Billing team should verify Wegovy injectable claims for BCBSND commercial members with MASH diagnosis are now covered regardless of weight loss benefits. Check if patients need new prior authorization for MASH diagnosis, especially if their weight loss benefits changed in 2026. Contact BCBSND Provider Service at 800-368-2312 for PA requirements and visit MyPrime.com for coverage details.